(HealthDay)—Octaplas has been approved by the U.S. Food and Drug Administration to augment insufficient clotting proteins that could otherwise lead to excessive bleeding or excessive clotting.
Jan 17, 2013
not rated yet | 0
Many premature infants suffer a life-threatening destruction of intestinal tissue called necrotizing enterocolitis (NEC).
Nov 21, 2011
5 / 5 (1) | 0